UK Earnings, Trading Statements Calendar | |
Wednesday, October 22 | |
City of London Investment Group | Interim Management Statement |
Senior | Interim Management Statement |
Development Securities | Half Year Results |
Petropavlovsk | Q3 Production Update |
Spirit Pub Company | Full Year Results |
British American Tobacco | Interim Management Statement |
Computacenter | Interim Management Statement |
GlaxoSmithKline | Q3 Results |
Home Retail Group | Half Year Results |
International Personal Finance | Interim Management Statement |
Laird | Interim Management Statement |
Playtech | Interim Management Statement |
Thursday, October 23 | |
Phoenix Group Holdings | Interim Management Statement |
Volution Group | Full Year Results |
Mountview Estates | Full Year Results |
Tesco | Half Year Results |
Ladbrokes | Interim Management Statement |
Mecom Group | Interim Management Statement |
Britivic | Interim Management Statement |
Anglo American | Q3 Production Report |
Anglo Platinum | Q3 Production Report |
Foreign & Colonial Investment Trust | Interim Management Statement |
Bloomsbury Publishing | Half Year Results |
Inchcape | Interim Management Statement |
Segro | Interim Management Statement |
St James's Place | Interim Management Statement |
Stobart Group | Half Year Results |
Unilever | Trading Statement |
SVG Capital | Interim Management Statement |
African Barrick Gold | Q3 Results |
Colt Group | Interim Management Statement |
National Express Group | Interim Management Statement |
Premier Foods | Interim Management Statement |
Reed Elsevier | Interim Management Statement |
Photo-Me International | Trading Statement |
Friday, October 24 | |
Dechra Pharmaceuticals | Interim Management Statement |
Shire | Q3 Results |
Vesuvius | Interim Management Statement |
Spectris | Interim Management Statement |
TSB Banking Group | Interim Management Statement |
Monday, October 27 | |
No Events Scheduled | |
Tuesday, October 28 | |
UBM | Interim Management Statement |
BP | Q3 Results |
Lloyds Banking Group | Interim Management Statement |
BG Group | Q3 Results |
Utilitywise | Full Year Results |
Copyright 2014 Alliance News Limited. All Rights Reserved. | |
![Thomson Reuters](https://static.lse.co.uk/images/news-logos/thomson-reuters-news-logo.png)
Industry groups back drugmakers' appeal in Zantac cancer lawsuits
June 20 (Reuters) - A bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued heartburn drug Zantac has received the backing of leading U.S. industry groups, including the United States Chamber of Commerce and Pharmaceutical Research and Manufacturers of America.
Read more